Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2009
Headcount
6
HQ
Hadar Am, Israel
Sector
Health Tech & Life Sciences
About
CMRLinx is a medical software company that develops and implements clinical information systems for eye care. Focusing on ophthalmology, CMRLinx provides a software solution that facilitates patient care by simplifying the capture, aggregation, transmittal, processing, and viewing of medical information. The AllvisionEMR system empowers healthcare providers to deliver high-quality care at low costs. AllvisionEMR was first implemented in 2004 and has implementations in North America and Europe.
Q&A
- What is CMRLinx's primary focus?
- CMRLinx is a medical software company that develops and implements clinical information systems specifically for eye care, focusing on ophthalmology.
- What is the name of CMRLinx's core software product?
- CMRLinx's core software product is the AllvisionEMR system.
- When was the AllvisionEMR system first implemented?
- The AllvisionEMR system was first implemented in 2004.
- Where has CMRLinx's AllvisionEMR system been implemented?
- The AllvisionEMR system has implementations in North America and Europe.
- What is CMRLinx's current operational status?
- CMRLinx is currently inactive, as of November 2018.
- In which country is CMRLinx headquartered?
- CMRLinx is headquartered in Israel.
- What business models does CMRLinx utilize?
- CMRLinx utilizes B2G and B2B business models.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical Workflow
Technologies
Platforms & InterfacesSoftware
Target customers
Government & CityHealthcare & Life SciencesHealthcareProviders
Business model
B2GB2B
Tags
healthcare-itsoftware-applicationsophthalmologyclinical-datadigital-healthcareclinical-workflow
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2009-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Nov 2018 |